Nature's Sunshine Products (NATR) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
27 Mar, 2026Executive summary
The 2026 Annual Meeting will be held on May 6, 2026, with shareholders voting on director elections, executive compensation, auditor ratification, and a new stock incentive plan.
2025 net sales reached $480.1 million, net income was $20.5 million, and adjusted EBITDA was $48.7 million, reflecting growth over the prior year.
Shareholders of record as of February 27, 2026, are entitled to vote, with one vote per share.
Proxy materials are available online, and voting can be done electronically or in person.
Voting matters and shareholder proposals
Shareholders will vote on electing eight directors, an advisory say-on-pay resolution, ratification of Deloitte & Touche LLP as auditor, and approval of the 2026 Stock Incentive Plan.
The Board recommends voting in favor of all proposals.
The deadline for submitting shareholder proposals for the 2026 meeting has passed; proposals for 2027 must be received by November 20, 2026.
Board of directors and corporate governance
Seven of eight directors are independent; average tenure is over three years.
Directors serve one-year terms, with age and term limits to ensure board refreshment.
The Board has separate Chair and CEO roles, regular executive sessions, and 100% independent Audit and Compensation Committees.
Four standing committees: Audit, Compensation, Governance, and Risk Management, all with independent members.
Board and committee meetings had high attendance in 2025.
Latest events from Nature's Sunshine Products
- Shareholders will vote on director elections, executive pay, auditor ratification, and a new stock plan.NATR
Proxy filing27 Mar 2026 - Record sales and EBITDA growth in 2025 driven by digital and global expansion.NATR
Q4 202510 Mar 2026 - Digital-first growth, premium products, and omni-channel reach drive strong financial outlook.NATR
Small-Cap Growth Virtual Investor Conference3 Feb 2026 - Q2 2024 sales and earnings declined, but cash and digital investments remain strong.NATR
Q2 20242 Feb 2026 - Q3 2025 saw record sales, margin expansion, and raised outlook on digital and Asia-Pacific strength.NATR
Q3 202529 Jan 2026 - Digital-first strategy and premium products drive growth and strong financial performance.NATR
2024 Annual Gateway Conference22 Jan 2026 - Q3 net sales up 3.1%, net income rose, and guidance increased on Asia and Europe strength.NATR
Q3 202415 Jan 2026 - Premium supplement brand drives global growth with digital, innovation, and margin expansion plans.NATR
2024 Southwest IDEAS Conference12 Jan 2026 - Q4 net sales up 8.5% to $118.2M; 2025 outlook cautious with $445–$470M sales guidance.NATR
Q4 202427 Dec 2025